Niki BioSolutions, Inc. (NIKI) stock
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
$1.60+0.10 (+6.67%)
Close on Nov 18, 2026Market cap $13.03MP/E –Yield –
Niki BioSolutions cash
Cash and short-term investments held at the end of each period.
Niki BioSolutions's cash was $3.45M at Dec 31, 2025. For fiscal 2025 it was $3.45M, up 295.0% from the year before. The highest annual figure on record is $27.12M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.45M | +295.0% |
| FY2024 | Dec 31, 2024 | $874.24K | -56.4% |
| FY2023 | Dec 31, 2023 | $2.01M | -60.8% |
| FY2022 | Dec 31, 2022 | $5.12M | -39.8% |
| FY2021 | Dec 31, 2021 | $8.50M | +134.4% |
| FY2020 | Dec 31, 2020 | $3.63M | -43.0% |
| FY2019 | Dec 31, 2019 | $6.36M | -76.6% |
| FY2018 | Dec 31, 2018 | $27.12M | +45.0% |
| FY2017 | Dec 31, 2017 | $18.70M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $3.45M | +357.6% |
| Q3 FY2025 | Sep 30, 2025 | $2.27M | +190.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.76M | +37.5% |
| Q4 FY2024 | Dec 31, 2024 | $874.24K | +156.9% |
| Q3 FY2024 | Sep 30, 2024 | $754.59K | -85.2% |
| Q2 FY2024 | Jun 30, 2024 | $783.09K | -80.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.01M | -76.4% |
| Q2 FY2023 | Jun 30, 2023 | $340.31K | -98.3% |
| Q4 FY2022 | Dec 31, 2022 | $5.12M | +41.1% |
| Q2 FY2022 | Jun 30, 2022 | $4.07M | -8.1% |
| Q4 FY2021 | Dec 31, 2021 | $8.50M | +33.7% |
| Q2 FY2021 | Jun 30, 2021 | $20.07M | +349.2% |
| Q4 FY2020 | Dec 31, 2020 | $3.63M | -86.6% |
| Q2 FY2020 | Jun 30, 2020 | $4.43M | -76.3% |
| Q4 FY2019 | Dec 31, 2019 | $6.36M | – |
| Q2 FY2019 | Jun 30, 2019 | $4.47M | – |
| Q4 FY2018 | Dec 31, 2018 | $27.12M | – |
| Q4 FY2017 | Dec 31, 2017 | $18.70M | – |
See a number that looks wrong?